Table 1 Baseline characteristics in patients with and without the combined endpoint (n = 227)
|  | All (n = 227) | No death, MI or HF (n = 142) | Death, MI or HF (n = 85) |  |
|---|---|---|---|---|
Variables | n (%) | n (%) | n (%) | P |
Demographics: | Â | Â | Â | Â |
Age (median, 25th–75th perc.) | 67 (59–77) | 62 (56–74) | 74 (63–80) | <0.001 |
Men | 172 (76) | 111 (78) | 61 (72) | 0.276 |
Risk factors: | Â | Â | Â | Â |
Hypertension | 121 (53) | 63 (44) | 58 (68) | <0.001 |
Diabetes Mellitus | 51 (22) | 29 (20) | 22 (26) | 0.340 |
Current smoker (missing n = 6) | 43 (19) | 33 (23) | 10 (13) | 0.049 |
Previous cardiovascular disease: | Â | Â | Â | Â |
Myocardial infarction | 56 (25) | 31 (22) | 25 (30) | 0.200 |
Heart Failure | 19 (8) | 2 (1) | 17 (20) | <0.001 |
Revascularization, PCI | 33 (15) | 23 (16) | 10 (12) | 0.359 |
Revascularization, CABG | 10 (4) | 4 (3) | 6 (7) | 0.132 |
Stroke | 17 (8) | 10 (7) | 7 (8) | 0.741 |
Laboratory measurements | Â | Â | Â | Â |
NTproBNP 24 h (median, 25th–75th perc.) (n = 189)) | 1220 (535–3465) | 724 (303–1887) | 2300 (1030–26040) | <0.001 |
eGFR (median, 25th–75th perc.) (n = 220) | 81 (58–110) | 92 (72–116) | 66 (40–96) | <0.001 |
Troponin I (median, 25th–75th perc.) (n = 207) | 3.5 (0.41–10.4) | 2.4 (0.28–9.6) | 4.4 (0.57–10.7) | 0.118 |
Index Diagnosis | Â | Â | Â | Â |
Myocardial infarction | 188 (83) | 119 (84) | 69 (81) | 0.612 |
Measurements of LV function | Â | Â | Â | Â |
EF simpson (median, 25th–75th perc.) | 49 (41–56) | 45 (35–52) | 52 (45–58) | <0.001 |
WMSI (median, 25th–75th perc.) | 1.06 (1.00–1.33) | 1.14 (1.00–1.56) | 1.00 (1.00–1.16) | <0.001 |
Intervention during admission | Â | Â | Â | Â |
Coronary angiography | 192 (85) | 132 (93) | 60 (70) | <0.001 |
PCI | 109 (48) | 81 (57) | 28 (33) | <0.001 |
CABG | 25 (11) | 13 (9) | 12 (14) | 0.248 |
Treatment at discharge | Â | Â | Â | Â |
Betablocker | 211 (93) | 135 (95) | 76 (89) | 0.114 |
Statin | 209 (92) | 137 (96) | 72 (85) | 0.003 |
ASA | 217 (96) | 141 (99) | 76 (89) | 0.001 |
Clopidogrel | 148 (65) | 103 (73) | 45 (53) | 0.003 |
ACE inhibitor/A2 blocker | 173 (76) | 101 (71) | 72 (85) | 0.012 |